Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost Power Disc-15 vs Power Disc-6 in PAH Extension Study
NCT00709098Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2008
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Sep 2008; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00709098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709098.